跳至主要内容
临床试验/CTRI/2017/03/008141
CTRI/2017/03/008141尚未招募未知

A comparative clinical study on the effect of virechana karma and mandura vajra vataka in the management of pandu w.s.r to iron deficiency anaemia

IPGT RA GAU Jamnagar Gujarat India0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patient having clinical sign & symptoms of Pandu
  • Patients having low Hb % (WHO Criteria)
  • For female 8 to 11gm%
  • For male 8 to 13gm%
  • Patients having low serum Iron (Normal Range is in male 59 to 148 μg/dl and
  • female 37 to 145 μg/dl)
  • MCV less than 80 fl
  • Patients having low serum ferritin. (Normal Range is in male 25 to 280 ng/ml and female less than 73.3 ng/ml)

排除标准

  • Patients unfit for the Virechana
  • Patients suffering from severe illnesses from AIDS, Cancer, Hypertension, Diabetes Mellitus & other severe diseases.
  • Haematological disorders like Sickle cell Anaemia, Thalassemia etc.
  • Pregnancy & lactating women
  • Patients having Hb < 8gm%.
  • Age below 18 years & more than 60 years.

研究者

发起方
IPGT RA GAU Jamnagar Gujarat India

相似试验

Effect of Virechana Karma and Mandura Vajra tablet... | 临床试验